Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
American Journal of Public Health|April 1, 1982
An independent analysis of the National Cancer Institute study on non-nutritive sweeteners and bladder cancerA M Walker, N A Dreyer, E Friedlander, et al.
Immunogenetics|February 9, 2011
The firstH- 2 mutant workshopH I Kohn, J Klein, R W Melvold, et al.
Journal of Medicinal Chemistry|July 19, 1996
Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacologyW F Pool, T F Woolf, M D Reily, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 19, 2004
Metabolism and excretion of capravirine, a new non-nucleoside reverse transcriptase inhibitor, alone and in combination with ritonavir in healthy volunteersHai-Zhi Bu, William F Pool, Ellen Y Wu, et al.
Journal of Reproduction and Fertility. Supplement|January 1, 1987
Exogenous hormone regimens to utilize successfully mares in dioestrus (days 2-14 after ovulation) as embryo transfer recipientsK F Pool, J M Wilson, G W Webb, et al.
The Journal of Experimental Medicine|December 1, 1979
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouseI F McKenzie, G M Morgan, M S Sandrin, et al.
The Journal of Experimental Medicine|May 1, 1980
Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K. A study with Kb mutantsC J Melief, L P de Waal, M Y van der Meulen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2011
Pharmacokinetics, distribution, and metabolism of [14C]sunitinib in rats, monkeys, and humansBill Speed, Hai-Zhi Bu, William F Pool, et al.
Pageof 9